Johnson & Johnson (JNJ)
JNJPrice: $242.04
Fair Value: 🔒
🔒score
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under t... more
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and se... more
Description
Shares
| Market Cap | $583.29B | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | US | CEO | Joaquin Duato |
| IPO Date | 1943-01-02 | CAGR | 0.07% |
| Employees | 138,100 | Website | www.jnj.com |
| Div. Yield | 0.11% | Payout Ratio | 0.49% |
| Buy Back Yield | 0.04% | Total Yield | 0.15% |
JNJ chart loading...
Fundamentals
Technicals
| Enterprise Value | $525.53B | P/E Ratio | 21.92 |
| Forward P/E | 19.02 | PEG Ratio | 0.45 |
| P/S Ratio | 133.72 | P/B Ratio | 156.86 |
| P/CF Ratio | 513.31 | P/FCF Ratio | 646.5 |
| EPS | $11.04 | EPS Growth 1Y | 90.85% |
| EPS Growth 3Y | 63.95% | EPS Growth 5Y | 100.54% |
| Revenue Growth 1Y | 6.05% | Gross Margin | 0.68% |
| Operating Margin | 0.26% | Profit Margin | 0.27% |
| ROE | 0.33% | ROA | 0.13% |
| ROCE | 0.17% | Current Ratio | 1.07 |
| Quick Ratio | 0.8 | Cash Ratio | 0.36 |
| Debt/Equity | 0.58 | Interest Coverage | 36.05 |
| Altman Z Score | 5.31 | Piotroski Score | 5 |